Comparison between HDB Financial IPO and Paramesu Biotech IPO.
HDB Financial IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Paramesu Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of HDB Financial IPO is up to ₹12,500.00 Cr whereas the issue size of the Paramesu Biotech IPO is up to ₹600.00 Cr. The final issue price of HDB Financial IPO is ₹740.00 per share and of Paramesu Biotech IPO is .
| HDB Financial IPO | Paramesu Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹5 per share |
| Issue Price (Lower) | ₹700.00 per share | |
| Issue Price (Upper) | ₹740.00 per share | |
| Issue Price (Final) | ₹740.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 20 shares | |
| Fresh Issue Size | 3,37,83,782 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹2,500.00 Cr | up to ₹520.00 Cr |
| OFS Issue Size | 13,51,35,135 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹10,000.00 Cr | up to ₹80.00 Cr |
| Issue Size Total | 16,89,18,917 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹12,500.00 Cr | up to ₹600.00 Cr |
HDB Financial IPO opens on Jun 25, 2025, while Paramesu Biotech IPO opens on . The closing date of HDB Financial IPO and Paramesu Biotech IPO is Jun 27, 2025, and , respectively.
| HDB Financial IPO | Paramesu Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Jun 24, 2025 | |
| Issue Open | Jun 25, 2025 | |
| Issue Close | Jun 27, 2025 | |
| Basis Of Allotment (Tentative) | Jun 30, 2025 | |
| Initiation of Refunds (Tentative) | Jul 01, 2025 | |
| Credit of Share (Tentative) | Jul 01, 2025 | |
| Listing date (Tentative) | Jul 02, 2025 | |
| Anchor Lockin End date 1 | Jul 29, 2025 | |
| Anchor Lockin End date 2 | Sep 27, 2025 |
HDB Financial IPO P/E ratio is 27, as compared to Paramesu Biotech IPO P/E ratio of .
| HDB Financial IPO | Paramesu Biotech IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)HDB Financial Services Ltd.'s revenue increased by 15% and profit after tax (PAT) dropped by 12% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 94.32 | 92.19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹61253.30 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.72% | 23.30% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 18.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹27.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.30% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the HDB Financial IPO Retail Individual Investors (RII) are offered 5,31,14,865 shares while in Paramesu Biotech IPO retail investors are offered 5,31,14,865 shares. Qualified Institutional Buyers (QIB) are offered 3,03,51,351 shares in HDB Financial IPO and 0 shares in Paramesu Biotech IPO.
| HDB Financial IPO | Paramesu Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,55,27,026 shares | |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 3,03,51,351 shares | 0 shares |
| NII | 2,27,63,514 shares | 0 shares |
| RII | 5,31,14,865 shares | 0 shares |
| Employee | 2,70,270 shares | 0 shares |
| Others | ||
| Total | 16,89,18,917 shares | 0 shares |
HDB Financial IPO subscribed 17.65x in total, whereas Paramesu Biotech IPO subscribed .
| HDB Financial IPO | Paramesu Biotech IPO | |
|---|---|---|
| QIB (times) | 58.64x | |
| NII (times) | 10.55x | |
| Big NII (times) | 12.44x | |
| Small NII (times) | 6.79x | |
| RII (times) | 1.51x | |
| Employee (times) | 6.03x | |
| Other (times) | 4.50x | |
| Total (times) | 17.65x |
